1. C. Drosten, S. Gunther, W. Preiser, et al. "Identification of a novel coronavirus in patients with severe acute respiratory syndrome," N Engl J Med, vol. 348, no. 20, pp. 1967-1976.
2. A.M. Zaki, S. van Boheemen, T.M. Bestebroer, A.D. Osterhaus, and R.A. Fouchier. "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia," N Engl J Med, vol. 367, no. 19, pp. 1814-1820.
3. J. Cui, F. Li, and Z.L. Shi. "Origin and evolution of pathogenic coronaviruses," Nat Rev Microbiol, vol. 17, no. 3, pp. 181-192.
4. H.L. Jiang, B. Mao, Y.Q. Zhong, H.M. Yang, and J.J. Fu. "[Tanreqing Injection for community-acquired pneumonia: a systematic review of randomized evidence]," Zhong Xi Yi Jie He Xue Bao, vol. 7, no. 1, pp. 9-19.
5. P. Wang, X. Liao, Y.M. Xie, Y. Chai, and L.H. Li. "Tanreqing injection for acute bronchitis disease: A systematic review and meta-analysis of randomized controlled trials," Complement Ther Med, vol. 25, pp. 143-158.
6. P.Y. Xie, Y.M. Xie, L.X. Wang, Y.P. Chang, L. You, and X.L. Zhang. "[Registration study on analysis of adaptation syndromes and medication characteristics of tanreqing injection]," Zhongguo Zhong Yao Za Zhi, vol. 39, no. 18, pp. 3571-3575.
7. Y. Wang, T. Wang, J. Hu, et al. "Anti-biofilm activity of TanReQing, a Traditional Chinese Medicine used for the treatment of acute pneumonia," J Ethnopharmacol, vol. 134, no. 1, pp. 165-170.
8. X.Y. Zhu, H.F. Xie, H. Han, and F. Gao. "[Network Meta-analysis of 3 kinds of Chinese medicine injections in treatment of acute exacerbations of chronic obstructive pulmonary disease]," Zhongguo Zhong Yao Za Zhi, vol. 44, no. 10, pp. 2179-2184.
9. X. Huang, X. Duan, Y. Zhu, K. Wang, J. Wu, and X. Tian. "Comparative efficacy of Chinese herbal injections for the treatment of community-acquired pneumonia: A Bayesian network meta-analysis of randomized controlled trials," Phytomedicine, vol. 63, p. 153009.
10. T. Pan, X. Liu, S. Xiang, and W. Ji. "Treatment for patients with multidrug resistant Acinetobacter baumannii pulmonary infection," Exp Ther Med, vol. 11, no. 4, pp. 1345-1347.
11. H. Zhu, M. Chen, X. Shi, C. Shi, and C. Huang. "Material basis studies of anti-Influenza A active ingredients in Tanreqing Injection," Biomed Chromatogr, vol. 32, no. 2.
12. Q. Luo, X. Shi, J. Ding, et al. "Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A," Evid Based Complement Alternat Med, vol. 2019, p. 1410495.
13. S. Wei, X. Zhou, M. Niu, et al. "Network pharmacology exploration reveals the bioactive compounds and molecular mechanisms of Li-Ru-Kang against hyperplasia of mammary gland," Mol Genet Genomics, vol. 294, no. 5, pp. 1159-1171.
14. T. Qin, L. Wu, Q. Hua, Z. Song, Y. Pan, and T. Liu. "Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation," J Ethnopharmacol, vol. 246, p. 112128.
15. Y. Jiang, N. Liu, S. Zhu, X. Hu, D. Chang, and J. Liu. "Elucidation of the Mechanisms and Molecular Targets of Yiqi Shexue Formula for Treatment of Primary Immune Thrombocytopenia Based on Network Pharmacology," Front Pharmacol, vol. 10, p. 1136.
16. Y. Qu, Z. Zhang, Y. Lu, Zheng, and Y. Wei. "Network Pharmacology Reveals the Molecular Mechanism of Cuyuxunxi Prescription in Promoting Wound Healing in Patients with Anal Fistula," Evid Based Complement Alternat Med, vol. 2019, p. 3865121.
17. Z. Meng, X. Liu, J. Wu, et al. "Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology," Evid Based Complement Alternat Med, vol. 2019, p. 4637839.
18. Y. Jiang, M. Zhong, F. Long, and R. Yang. "Deciphering the Active Ingredients and Molecular Mechanisms of Tripterygium hypoglaucum (Levl.) Hutch against Rheumatoid Arthritis Based on Network Pharmacology," Evid Based Complement Alternat Med, vol. 2020, p. 2361865.
19. H. Yang, Y. Li, S. Shen, et al. "Network Pharmacology-Based Investigation into the Mechanisms of Quyushengxin Formula for the Treatment of Ulcerative Colitis," Evid Based Complement Alternat Med, vol. 2019, p. 7870424.
20. C. Li, C. Zang, Q. Nie, B. Yang, B. Zhang, and S. Duan. "Simultaneous determination of seven flavonoids, two phenolic acids and two cholesterines in Tanreqing injection by UHPLC-MS/MS," J Pharm Biomed Anal, vol. 163, pp. 105-112.
21. S.X. Feng, X.H. Li, M.M. Wang, et al. "A sensitive HPLC-MS method for simultaneous determination of thirteen components in rat plasma and its application to pharmacokinetic study of Tanreqing injection," J Pharm Biomed Anal, vol. 148, pp. 205-213.
22. F. Zhang, L. Sun, S.H. Gao, W.S. Chen, and Y.F. Chai. "LC-MS/MS analysis and pharmacokinetic study on five bioactive constituents of Tanreqing injection in rats," Chin J Nat Med, vol. 14, no. 10, pp. 769-775.
23. S.Y. Liu, D.S. Xue, J.C. Pan, W.M. Zhang, W.L. Li, and H.B. Qu. "Screening and identification of multiple components in Tanreqing injection using RP-HPLC combined with DAD and ESI-TOF/MS," Chin J Nat Med, vol. 12, no. 7, pp. 535-541.
24. W. Li, X. Yan, J. Pan, S. Liu, D. Xue, and H. Qu. "Rapid analysis of the Tanreqing injection by near-infrared spectroscopy combined with least squares support vector machine and Gaussian process modeling techniques," Spectrochim Acta A Mol Biomol Spectrosc, vol. 218, pp. 271-280.
25. Y. Zhao, Z. Xu, T. Wang, et al. "Simultaneous quantitation of 23 bioactive compounds in Tanreqing capsule by high-performance liquid chromatography electrospray ionization tandem mass spectrometry," Biomed Chromatogr, vol. 33, no. 7, p. e4531.
26. W. Liu, X. Zhang, B. Mao, and H. Jiang. "Systems pharmacology-based study of Tanreqing injection in airway mucus hypersecretion," J Ethnopharmacol, vol. 249, p. 112425.
27. W. Li, Z. Cheng, Y. Wang, and H. Qu. "A study on the use of near-infrared spectroscopy for the rapid quantification of major compounds in Tanreqing injection," Spectrochim Acta A Mol Biomol Spectrosc, vol. 101, pp. 1-7.
28. S. Kim. "Getting the most out of PubChem for virtual screening," Expert Opin Drug Discov, vol. 11, no. 9, pp. 843-855.
29. S. Kim, J. Chen, T. Cheng, et al. "PubChem 2019 update: improved access to chemical data," Nucleic Acids Res, vol. 47, no. D1, pp. D1102-D1109.
30. D. Szklarczyk, A. Santos, C. von Mering, L.J. Jensen, P. Bork, and M. Kuhn. "STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data," Nucleic Acids Res, vol. 44, no. D1, pp. D380-384.
31. M. Hong, S. Li, H.Y. Tan, et al. "A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines," Molecules, vol. 22, no. 4.
32. D. Gfeller, A. Grosdidier, M. Wirth, A. Daina, O. Michielin, and V. Zoete. "SwissTargetPrediction: a web server for target prediction of bioactive small molecules," Nucleic Acids Res, vol. 42, no. Web Server issue, pp. W32-38.
33. A. Daina, O. Michielin, and V. Zoete. "SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules," Nucleic Acids Res, vol. 47, no. W1, pp. W357-W364.
34. J. Wang, S. Zhao, M. Liu, et al. "ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism," medRxiv, p. 2020.2002.2005.20020545.
35. D. Szklarczyk, J.H. Morris, H. Cook, et al. "The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible," Nucleic Acids Res, vol. 45, no. D1, pp. D362-D368.
36. C.H. Chin, S.H. Chen, H.H. Wu, C.W. Ho, M.T. Ko, and C.Y. Lin. "cytoHubba: identifying hub objects and sub-networks from complex interactome," BMC Syst Biol, vol. 8 Suppl 4, p. S11.
37. G. Su, J.H. Morris, B. Demchak, and G.D. Bader. "Biological network exploration with Cytoscape 3," Curr Protoc Bioinformatics, vol. 47, pp. 8 13 11-24.
38. M. Ashburner, C.A. Ball, J.A. Blake, et al. "Gene ontology: tool for the unification of biology. The Gene Ontology Consortium," Nat Genet, vol. 25, no. 1, pp. 25-29.
39. M. Kanehisa, S. Goto, S. Kawashima, Y. Okuno, and M. Hattori. "The KEGG resource for deciphering the genome," Nucleic Acids Res, vol. 32, no. Database issue, pp. D277-280.
40. C. Zhang, Y. Zheng, X. Li, X. Hu, F. Qi, and J. Luo. "Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma," Ann Transl Med, vol. 7, no. 18, p. 427.
41. G. Yu, L.G. Wang, Y. Han, and Q.Y. He. "clusterProfiler: an R package for comparing biological themes among gene clusters," OMICS, vol. 16, no. 5, pp. 284-287.
42. P. Zhou, X.L. Yang, X.G. Wang, et al. "A pneumonia outbreak associated with a new coronavirus of probable bat origin," Nature, vol. 579, no. 7798, pp. 270-273.
43. X.Y. Ge, J.L. Li, X.L. Yang, et al. "Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor," Nature, vol. 503, no. 7477, pp. 535-538.
44. W. Song, M. Gui, X. Wang, and Y. Xiang. "Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2," PLoS Pathog, vol. 14, no. 8, p. e1007236.
45. K. Kuba, Y. Imai, S. Rao, et al. "A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury," Nat Med, vol. 11, no. 8, pp. 875-879.
46. M. Vaillancourt, P. Chia, S. Sarji, et al. "Autonomic nervous system involvement in pulmonary arterial hypertension," Respir Res, vol. 18, no. 1, p. 201.
47. F. Huang, J. Guo, Z. Zou, et al. "Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients," Nat Commun, vol. 5, p. 3595.
48. W.A. Hsueh and K. Wyne. "Renin-Angiotensin-aldosterone system in diabetes and hypertension," J Clin Hypertens (Greenwich), vol. 13, no. 4, pp. 224-237.
49. M. Mogi and M. Horiuchi. "Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases," Geriatr Gerontol Int, vol. 13, no. 1, pp. 13-18.
50. D. Shrikrishna, R. Astin, P.R. Kemp, and N.S. Hopkinson. "Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease," Clin Sci (Lond), vol. 123, no. 8, pp. 487-498.
51. S.A. Rasmussen, J.C. Smulian, J.A. Lednicky, T.S. Wen, and D.J. Jamieson. "Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know," Am J Obstet Gynecol.
52. N. Chen, M. Zhou, X. Dong, et al. "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study," Lancet, vol. 395, no. 10223, pp. 507-513.
53. Q. Zhao, X.Y. Chen, and C. Martin. "Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plants," Sci Bull (Beijing), vol. 61, no. 18, pp. 1391-1398.
54. H.C. Zhou, R. Du, H. Wang, et al. "[Advance in studies on pharmacokinetics of baicalin]," Zhongguo Zhong Yao Za Zhi, vol. 43, no. 4, pp. 684-688.
55. B. Dinda, S. Dinda, S. DasSharma, R. Banik, A. Chakraborty, and M. Dinda. "Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders," Eur J Med Chem, vol. 131, pp. 68-80.
56. Y. Li, W. Li, C. Fu, Y. Song, and Q. Fu. "Lonicerae japonicae flos and Lonicerae flos: a systematic review of ethnopharmacology, phytochemistry and pharmacology," Phytochem Rev, pp. 1-61.
57. M. Matejczyk, R. Swislocka, M. Kalinowska, G. Swidersk, W. Lewandowsk, and A. Jablonska-Trypuo. "Monitoring of Synergistic Enhancement of Caffeic Acid on Escherichia Coli K-12 Reca::Gfp Strain Treated with Dacarbazine," Acta Pol Pharm, vol. 74, no. 3, pp. 809-816.
58. J. Santana-Galvez, L. Cisneros-Zevallos, and D.A. Jacobo-Velazquez. "Chlorogenic Acid: Recent Advances on Its Dual Role as a Food Additive and a Nutraceutical against Metabolic Syndrome," Molecules, vol. 22, no. 3.
59. J. Bao, R. Ding, L. Zou, et al. "Forsythiae Fructus Inhibits B16 Melanoma Growth Involving MAPKs/Nrf2/HO-1 Mediated Anti-Oxidation and Anti-Inflammation," Am J Chin Med, vol. 44, no. 5, pp. 1043-1061.
60. X. Pan, X. Cao, N. Li, et al. "Forsythin inhibits lipopolysaccharide-induced inflammation by suppressing JAK-STAT and p38 MAPK signalings and ROS production," Inflamm Res, vol. 63, no. 7, pp. 597-608.
61. V.G. Radchenko, P.V. Seliverstov, and S.I. Sitkin. "[New aspects of pharmacological effects of ursodeoxycholic acid]," Eksp Klin Gastroenterol, no. 8, pp. 4-10.
62. P. Zhou, X.-L. Yang, X.-G. Wang, et al. "Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin," bioRxiv, p. 2020.2001.2022.914952.
63. A. Habibovic, M. Hristova, D.E. Heppner, et al. "DUOX1 mediates persistent epithelial EGFR activation, mucous cell metaplasia, and airway remodeling during allergic asthma," JCI Insight, vol. 1, no. 18, p. e88811.
64. A.Z. El-Hashim, M.A. Khajah, W.M. Renno, et al. "Src-dependent EGFR transactivation regulates lung inflammation via downstream signaling involving ERK1/2, PI3Kdelta/Akt and NFkappaB induction in a murine asthma model," Sci Rep, vol. 7, no. 1, p. 9919.
65. K. Tsuchiya, T. Jo, N. Takeda, et al. "EGF receptor activation during allergic sensitization affects IL-6-induced T-cell influx to airways in a rat model of asthma," Eur J Immunol, vol. 40, no. 6, pp. 1590-1602.
66. E.J. Hillmer, H. Zhang, H.S. Li, and S.S. Watowich. "STAT3 signaling in immunity," Cytokine Growth Factor Rev, vol. 31, pp. 1-15.
67. J. Wienke, W. Janssen, R. Scholman, et al. "A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation," Oncotarget, vol. 6, no. 24, pp. 20037-20042.
68. X. Dong, M. Xu, Z. Ren, et al. "Regulation of CBL and ESR1 expression by microRNA-223p, 513a-5p and 625-5p may impact the pathogenesis of dust mite-induced pediatric asthma," Int J Mol Med, vol. 38, no. 2, pp. 446-456.
69. I. Hamming, W. Timens, M.L. Bulthuis, A.T. Lely, G. Navis, and H. van Goor. "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis," J Pathol, vol. 203, no. 2, pp. 631-637.
70. N.L. Wu, D.Y. Huang, H.N. Tsou, Y.C. Lin, and W.W. Lin. "Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6," J Invest Dermatol, vol. 135, no. 2, pp. 490-498.
71. H.W. Song, C. Yang, W. Liu, X.W. Liu, Z. Liu, and F. Gao. "Interleukin-17A Plays the Same Role on Mice Acute Lung Injury Respectively Induced by Lipopolysaccharide and Paraquat," Inflammation, vol. 40, no. 5, pp. 1509-1519.